FOAK Risk Is Execution, Not IP

In climate technology, discussion often centres on intellectual property, laboratory validation, peer review, and pilot performance. These elements are essential. However, in first-of-a-kind (FOAK) chemical projects, technical IP is rarely the primary source of failure.

Execution risk is.

When a FOAK plant experiences an 18-month delay, the root cause is seldom a reaction that stopped working. More often, it is external and operational: archaeological clearance delaying site works, equipment lead times extending beyond plan, EPC selection issues, underestimated grid connection complexity, or unforeseen ground conditions increasing infrastructure costs.

In laboratory development, chemistry determines feasibility. In industrial deployment, schedule discipline determines viability. Every day of delay directly impacts capital efficiency and cash flow.

Execution Experience as a Strategic Asset

Alta Group is advancing its project to produce 2,3 kilotonnes of propylene carbonate using its proprietary catalyst platform. The company’s core team brings experience from the construction and commissioning of more than 70 industrial plants. This background fundamentally shapes how a FOAK project is prepared and structured.

Key considerations during preparation include:

  •  Sourcing reactors and major equipment from established suppliers
  •  Identifying long-lead components early in the schedule
  •  Securing reliable CO₂ feedstock supply
  •  Mapping logistical bottlenecks for critical hardware
  •  Structuring modular capacity expansion to limit capital exposure

This approach prioritises execution certainty from the outset.

Modular Scale-Up to Control Risk

While chemical production benefits from economies of scale, oversizing a FOAK facility can amplify risk. Alta’s strategy therefore adopts a modular architecture. Production capacity is structured into repeatable “trains,” each functioning as a standardised unit.

This model delivers two advantages:

1. Timeline predictability. Repetition of validated modules reduces engineering uncertainty and accelerates procurement and construction cycles.

2. Capital risk management. Capacity can be expanded incrementally, allowing investment to scale alongside validated operational performance.

Alta’s planned ramp-up reflects staged capacity growth, aligned with commercial traction and operational validation.

From Technology to Delivery

FOAK does not inherently imply excessive risk. It represents the first industrial implementation of a proven concept — executed with disciplined planning and structured scale-up.

Chemistry creates opportunity. Execution determines whether that opportunity becomes operational capacity delivered to customers. For Alta Group, execution readiness is not a secondary consideration. It is central to bringing carbon-efficient battery chemicals to market at industrial scale.